Cerebrotendineous xanthomatosis

(Redirected from Van Bogaert's disease)
Jump to navigation Jump to search
Cerebrotendineous xanthomatosis
ICD-10 E75.5
ICD-9 272.7
OMIM 213700
DiseasesDB 29239
MeSH D019294

WikiDoc Resources for Cerebrotendineous xanthomatosis

Articles

Most recent articles on Cerebrotendineous xanthomatosis

Most cited articles on Cerebrotendineous xanthomatosis

Review articles on Cerebrotendineous xanthomatosis

Articles on Cerebrotendineous xanthomatosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cerebrotendineous xanthomatosis

Images of Cerebrotendineous xanthomatosis

Photos of Cerebrotendineous xanthomatosis

Podcasts & MP3s on Cerebrotendineous xanthomatosis

Videos on Cerebrotendineous xanthomatosis

Evidence Based Medicine

Cochrane Collaboration on Cerebrotendineous xanthomatosis

Bandolier on Cerebrotendineous xanthomatosis

TRIP on Cerebrotendineous xanthomatosis

Clinical Trials

Ongoing Trials on Cerebrotendineous xanthomatosis at Clinical Trials.gov

Trial results on Cerebrotendineous xanthomatosis

Clinical Trials on Cerebrotendineous xanthomatosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cerebrotendineous xanthomatosis

NICE Guidance on Cerebrotendineous xanthomatosis

NHS PRODIGY Guidance

FDA on Cerebrotendineous xanthomatosis

CDC on Cerebrotendineous xanthomatosis

Books

Books on Cerebrotendineous xanthomatosis

News

Cerebrotendineous xanthomatosis in the news

Be alerted to news on Cerebrotendineous xanthomatosis

News trends on Cerebrotendineous xanthomatosis

Commentary

Blogs on Cerebrotendineous xanthomatosis

Definitions

Definitions of Cerebrotendineous xanthomatosis

Patient Resources / Community

Patient resources on Cerebrotendineous xanthomatosis

Discussion groups on Cerebrotendineous xanthomatosis

Patient Handouts on Cerebrotendineous xanthomatosis

Directions to Hospitals Treating Cerebrotendineous xanthomatosis

Risk calculators and risk factors for Cerebrotendineous xanthomatosis

Healthcare Provider Resources

Symptoms of Cerebrotendineous xanthomatosis

Causes & Risk Factors for Cerebrotendineous xanthomatosis

Diagnostic studies for Cerebrotendineous xanthomatosis

Treatment of Cerebrotendineous xanthomatosis

Continuing Medical Education (CME)

CME Programs on Cerebrotendineous xanthomatosis

International

Cerebrotendineous xanthomatosis en Espanol

Cerebrotendineous xanthomatosis en Francais

Business

Cerebrotendineous xanthomatosis in the Marketplace

Patents on Cerebrotendineous xanthomatosis

Experimental / Informatics

List of terms related to Cerebrotendineous xanthomatosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Cerebrotendineous xanthomatosis (or cerebrotendinous xanthomatosis, with one fewer 'e', or Van Bogaert-Scherer-Epstein syndrome, or cerebrotendinous cholesterosis) is a form of xanthomatosis associated with the CYP27A1 gene on chromosome 2.

An inherited disorder associated with the deposition of a form of cholesterol in the brain and other tissues and with elevated levels of cholesterol in plasma but with normal total cholesterol level; it is characterized by progressive cerebellar ataxia beginning after puberty and by juvenile cataracts, and tendineous or tuberous xanthomas.

External links

Template:Endocrine, nutritional and metabolic pathology

Template:WikiDoc Sources